| EBITDA Margin guidance | 22.0% → 25.0% Raised by 3.0 percentage points |
|---|---|
| Management target | Revenue FY27 |
| Revenue growth | 5% annual revenue growth to 288Cr in FY26. |
|---|---|
| Margins | EBITDA margin stable at 22%; aiming for 25% post-expansion. |
| Demand visibility | Strong IV fluid demand, especially for advanced two-port systems. |
| Management confidence | High, focused on specialized high-margin product mix and cost efficiency. |
Growth
Revenue grew 5% YoY to 288Cr, while PAT surged 42% supported by better operating leverage and debt refinancing.
Outlook
EBITDA margins guided to expand from 22% to 25% following Steriport expansion and solar project commissioning.
Risks
Rising polymer costs (60-70% spike) and temporary inventory pile-ups during capacity ramp-up represent short-term headwinds.
Last quarter's promises, checked
Delivered
- Debt-to-equity ratio 3x → delivered ~1x (= BEAT)
- SteriPort revenue share → delivered 42% (= BEAT)
- EBITDA margin → delivered 22% (= BEAT)
Partly delivered
- Solar project commissioning → delivered 5-6 days away (= PARTIAL)
- SteriPort capacity expansion → delivered June 20th target (= PARTIAL)
Earnings Call Transcript filed with BSE, NSE: AMANTA. Summary written with AI assistance from the document.
Amanta Healthcare Ltd: key numbers
- Share price
- ₹186.00
- Market cap
- ₹722.2 Cr
- Revenue (annual)
- ₹287.7 Cr
- Net profit (annual)
- ₹14.88 Cr
- P/E (TTM)
- 49.2×Sector 50.4×
- Promoter holding
- 63.80%+0.08% QoQ
- FII holding
- 0.43%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Amanta Healthcare Ltd
All →Amanta Healthcare Management Change
Amanta Healthcare Limited appointed Nimesh P Patel as Non-Executive Non-Independent Director. The company also appointed M/s. Kashyap R. Mehta & Partners as the Secretarial Auditor.
Amanta Healthcare Annual General Meeting
Amanta Healthcare held its 31st Annual General Meeting on September 16, 2026, transacting ordinary and special business items via video conferencing.
Amanta Healthcare Production Started
Amanta Healthcare has commenced production at its new SteriPort facility at the Kheda campus. This brownfield expansion aims to improve operational efficiency and EBITDA margins.
Amanta Healthcare Investor Presentation: Key Takeaways
Amanta reported Q1FY27 revenue of INR 69 Cr (5% YoY) with 21% EBITDA margins. Strategy focuses on high-margin SteriPort/SVP capacity expansion and cost optimization via solar power.
- Call
- Guides 20% growth
Amanta Healthcare Q1 FY27 Results: Net Profit ₹3.3 Cr, Down 5.7% YoY
Amanta Healthcare Ltd reported revenue from operations of ₹68.8 Cr (+5.4% YoY) and net profit of ₹3.3 Cr (-5.7% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3.3 Cr · -5.7% YoY
Amanta Healthcare Earnings Call: Key Takeaways
Amanta reported FY26 revenue of ₹288cr with 22% EBITDA margins. Strategy focuses on high-margin SteriPort capacity expansion and renewable energy cost savings.